PL02.04. Risvutatug Rezetecan (a B7-H3-Directed ADC) Versus Topotecan in Relapsed SCLC: Primary Results of Phase 3 ARTEMIS-008

Sunday, September 13, 2026 9:11 AM to 9:21 AM · 10 min. (Asia/Seoul)

Join the event!

See all the content and easy-to-use features by logging in or registering!